Cargando…
p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
BACKGROUND: Non-small-cell lung carcinomas (NSCLCs) exhibit poor prognosis and are usually resistant to conventional chemotherapy. Absence of p21WAF1/CIP1, a cyclin-dependent kinase (cdk) inhibitor, has been linked to drug resistance in many in vitro cellular models. RNA activation (RNAa) is a trans...
Autores principales: | Wei, Junxia, Zhao, Jiang, Long, Min, Han, Yuan, Wang, Xi, Lin, Fang, Ren, Jihong, He, Ting, Zhang, Huizhong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995802/ https://www.ncbi.nlm.nih.gov/pubmed/21087528 http://dx.doi.org/10.1186/1471-2407-10-632 |
Ejemplares similares
-
Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019) -
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996) -
Regenerative Response in Ischemic Brain Restricted by p21(cip1/waf1)
por: Qiu, Jianhua, et al.
Publicado: (2004) -
p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin
por: Molnar, Zoltan, et al.
Publicado: (2014) -
The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle
regulator in oral squamous cell carcinoma (Review).
por: Pérez-Sayáns, Mario, et al.
Publicado: (2013)